Clinical Trial Update: DKK3 for Prognosis and Monitoring of GFR Decline in Heart Failure

View source ↗

Summary

A completed clinical trial assessing the biomarker DKK3 for prognosis and monitoring GFR decline in heart failure patients, including those with chronic kidney …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Heart Failure

Snippet

Sponsor: University of Giessen | Conditions: Heart Failure, Chronic Kidney Diseases | Status: COMPLETED